View Clinical Trial (Medical Research Study)
Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients
| City: |
|
Boston |
| State: |
|
Massachusetts |
| Zip Code: |
|
02114 |
| Conditions: |
|
Burns |
| Purpose: |
|
The purpose of the study is to understand the way the body uses amino acids and proteins in
burned patient during the time they cannot eat normally. This study aims to understand the
metabolism of the amino acid arginine in the body after burn injury. The results of this
study will help determine the best composition of food needed during an acute burn injury so
that body can more efficiently use the supplied nutrient for optimal burn wound healing and
early recovery.
|
| Study Summary: |
|
The principle sources of plasma free arginine are (i) diet, (ii) release from protein
breakdown and (iii) de novo synthesis directly from citrulline and the recycling of
orthinine via the urea cycle. The major pathway of arginine disposal is i)oxidation via
orthinine glutamate and subsequently the Tricarboxylic Acid (TCA) cycle and ii)via formation
of nitric oxide. The latter pathway plays an important regulatory role in the body's
response to stress and is significantly increased after burn injury.
Previous studies with burn patients show i)an increased rate of total arginine flux, ii)a
limited rate of arginine de novo synthesis, and iii) an apparent increase in the rate of
arginine catabolism as measured indirectly by increased orinthine oxidation. These changes
render arginine a conditionally essential amino acid for burn patients. Studies have shown
that feeding glutamine to healthy adults significantly alters the blood concentrations of
urea cycle intermediates arginine, citrulline and orthinine. Therefore, we hypothesize that
the availability of arginine can be improved in the burn patient by supplementing total
parenteral nutrition (TPN) support with glutamine.
Using stable isotope tracer studies our specific aims are:
1. To explore the dynamic aspects of arginine and citrulline metabolism. There will be an
emphasis on arginine disposal via oxidation and urea nitrogen formation via nitric
oxide production.
2. To explore the effect of a) depleting arginine and its immediate precursors proline and
glutamine, and b)glutamine supplementation on the metabolic pathways of burn patients.
3. To estimate the rate of nitric oxide (NO) formation in burn patients using arginine and
citrulline tracers
|
| Criteria: |
|
Inclusion Criteria:
- Burn patients being treated at MGH Burn Unit with one or more of the following
criteria: 1) >=5% TBSA; 2) inhalation injury; or 3) resting energy expenditure (REE)
of >15% of the predicted Basal Metabolic Rate using the Harris-Benedict equation.
- Must be receiving total parenteral nutrition in the course of their treatment.
Exclusion Criteria:
- Patients with thyroid disease
- Patients who are not hemodynamically stable or show unstable vital signs
- Patients at the stage of major organ failure, e.g. renal and/or liver failure.
|
| NCT ID: |
|
NCT00216970 |
| Primary Contact: |
|
Principal Investigator
Ronald G. Tompkins, MD, ScD
MGH, Shriner's Burn Hospital -Boston
Mary-Liz C Bilodeau, MS
Phone: 617-726-8766
Email: mbilodeau@partners.org
|
| Backup Contact: |
|
Yong-Ming Yu, MD, PhD
|
| Location Contact: |
|
Boston, Massachusetts 02114
United States
Colleen M
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|